$CI (Cigna Corp.)

$CI {{ '2015-12-01T15:56:15+0000' | timeago}} • SEC

$CI's mail order pharmacy revenues for 3Q15 increased by 10% from last year, largely driven by increased volume due to its higher customer base and home delivery utilization as well as higher prices to recover pharmacy cost trend. Net investment income fell by 2% on lower investment yields and unfavorable foreign currency effects.

$CI {{ '2017-06-08T17:47:25+0000' | timeago}} • Announcement

$CI and $CVS announced the launch of Cigna Health WorksSM, a new collaboration that aligns Cigna-administered health benefits with CVS Pharmacy and CVS MinuteClinic retail health care services to deliver a consumer-friendly experience for Cigna self-funded employer-sponsored health plans.

$CI {{ '2017-05-05T15:12:24+0000' | timeago}} • Webcast

$CI said that the Medicaid business in Illinois, which company has planned to exit, is running at near breakeven. $CI is not characterizing this business as a major headwind or tailwind in terms of the impact. The individual commercial business is in line with expectations and margins were negative, but still better than last year, $CI said.

$CI {{ '2017-05-05T15:02:51+0000' | timeago}} • Infographic

$CI Cigna Corp. Earnings AlphaGraphics: Q1 2017 highlights

$CI {{ '2017-05-05T14:56:28+0000' | timeago}} • Webcast

Relative to Monday's Delaware chancery court review and decision, $CI said that it will not speculate the outcome or timing on that. Earlier, $CI sued $ANTM to collect the breakup fee and damages after its merger agreement with Anthem got failed.

$CI {{ '2017-05-05T14:40:05+0000' | timeago}} • Webcast

$CI stated that Medicaid is a small business for it and saw an increase in Medicaid MCR in Texas and Illinois towards the end of the last year and elevated a little bit in 1Q17. $CI does not plan to participate in the Illinois Medicaid market beyond the end of this year. The exit of that business is considered in the outlook, the company said.

$ANTM {{ '2017-05-05T14:40:01+0000' | timeago}} • Announcement

$ANTM confirmed that it is filing a petition for a writ of certiorari with the U.S. Supreme Court, seeking review of the U.S. Court of Appeals for the D.C. Circuit’s majority decision regarding the acquisition of $CI.

$CI {{ '2017-05-05T11:15:06+0000' | timeago}} • Announcement

For FY17, $CI sees FY17 consolidated adjusted income from operations at $2.41-2.53Bil, or $9.25 to $9.75 per share. The outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment. Total revenue growth is expected at 3-4% for the year

$CI {{ '2017-05-05T11:11:14+0000' | timeago}} • Announcement

Total revenues for $CI improved 5% to $10.4Bil in 1Q17, as the health services organization's net income jumped 15% to $598MM from $519MM a year ago, Earnings rose to $2.30 per share from $2.00 a share, as Cigna ended the quarter with cash and marketable investments of $2.7Bil.

$ANTM {{ '2017-04-26T19:33:21+0000' | timeago}} • Webcast

$ANTM said that the Appeals Court verdict can go in three directions with regards to the pending $CI transaction; a) deny the company's appeal, b) accept, but in part and c) accept its appeal in its entirety. After the court's decision, the company will make the best choice. $ANTM added that it is committed to close the acquisition.

$ANTM {{ '2017-02-15T15:08:47+0000' | timeago}} • Announcement

$ANTM filed a suit seeking a temporary restraining order to enjoin $CI from terminating the merger agreement. This is in response to $CI's wrongful purported termination and lawsuit and ongoing campaign to sabotage the merger and deflect attention from its repeated willful breaches of the merger agreement.

$ANTM {{ '2017-02-15T15:07:17+0000' | timeago}} • Announcement

$ANTM filed a lawsuit in the Delaware Court of Chancery seeking a temporary restraining order to enjoin $CI from terminating, and taking any action contrary to the terms of, the Merger Agreement, specific performance compelling $CI to comply with the Merger Agreement and damages.

$ANTM {{ '2017-02-09T15:15:16+0000' | timeago}} • Announcement

$ANTM commented on the decision by the District Court of Columbia granting the Department of Justice’s request to block $ANTM's proposed acquisition of $CI. $ANTM promptly plans to file a notice of appeal and request an expedited hearing of its appeal to reverse the Court’s decision.

$CI {{ '2017-02-02T19:59:56+0000' | timeago}} • Webcast

For 2017, $CI expects Global Healthcare earnings in the range of approx. $2.035-2.115Bil. Full-year 2017 medical cost trend is expected to be 4.5-5.5%. For Global Supplemental Benefits, $CI expects earnings of $295-315MM reflecting business growth. For Group Disability and Life, earnings are expected to be $200-230MM.

$CI {{ '2017-02-02T19:53:23+0000' | timeago}} • Webcast

In $CI’s Group Disability and Life business, full year 2016 results reflect premium and fee growth of 4% over 2015. Full-year 2016 earnings in the Group business were $125MM with 4Q16 earnings of $69MM.

$CI {{ '2017-02-02T19:49:26+0000' | timeago}} • Webcast

For $CI’s total US Commercial book of business, full-year 2016 medical cost trend was modestly below the low end of the guidance range of 4-5%. Total Government medical care ratio of 85.3% reflects solid performance in the Medicare Advantage business and increased medical costs in the Medicaid business.

$CI {{ '2017-02-02T12:18:10+0000' | timeago}} • Announcement

$CI expects its FY17 con consolidated adjusted income from operations is in the range of $2.35-$2.48 Bil, or $9.00-9.50 per share. $CI's outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment.

$CI {{ '2017-02-02T12:14:56+0000' | timeago}} • Announcement

$CI reported a 10% YoY growth in its premiums and fees from Global Supplemental Benefits. This rise reflected continued business growth. the premiums and fees rose 4% YoY in the Group Disability and Life segment. This rise was mainly due to business growth across disability and life products.

$CI {{ '2017-02-02T12:09:37+0000' | timeago}} • Announcement

During 4Q16, $CI's premiums and fees from Global Health Care Segment increased 2% YoY, helped by customer growth, specialty contributions, and rate actions in our Commercial business. This was partially offset by reductions in Medicare Part D and Individual customers.

$CI {{ '2017-02-02T12:07:15+0000' | timeago}} • Announcement

Health insurer $CI reported a 10% drop in its 4Q16 earnings, hurt by transaction costs related to $CI's proposed combination with Anthem. Net income fell to $382MM, or $1.47 per share, compared to $426MM, or $1.64 per share during 4Q15. Revenues was $9.94Bil. Adjusted EPS from operations remained flat at $1.87 per share.

$CI {{ '2016-11-03T18:04:22+0000' | timeago}} • Infographic

$CI Cigna Earnings AlphaGraph: Q3 2016 Highlights

Recent Transcripts

AMGN (Amgen Inc)
Tuesday, July 25 2017 - 9:00pm
LLY (Eli Lilly and Company)
Tuesday, July 25 2017 - 1:00pm
DGX (Quest Diagnostics Inc.)
Tuesday, July 25 2017 - 12:30pm
CNC (Centene Corp.)
Tuesday, July 25 2017 - 12:30pm
BIIB (Biogen Inc.)
Tuesday, July 25 2017 - 12:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
ENZ (Enzo Biochem Inc.)
Friday, June 9 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Thursday, May 4 2017 - 9:00pm
ABC (AmerisourceBergen Corporation)
Thursday, May 4 2017 - 12:30pm
MET (MetLife, Inc.)
Thursday, May 4 2017 - 12:00pm
ALL (The Allstate Corporation)
Wednesday, May 3 2017 - 1:00pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
OMI (Owens & Minor Inc.)
Wednesday, May 3 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
GILD (Gilead Sciences Inc.)
Tuesday, May 2 2017 - 8:30pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
CNO (CNO Financial Group, Inc.)
Thursday, April 27 2017 - 3:00pm
ABBV (AbbVie Inc.)
Thursday, April 27 2017 - 1:00pm

AlphaGraphics you may like